Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Bell

Showing results (871-880 of 1,199) with videos related to

Pageof 120
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Epidermal growth factor receptor mutation testing in the care of lung cancer patientsLecia V Sequist, Victoria A Joshi, Pasi A Jänne, et al.
Surgical Endoscopy|June 1, 2014
Univariate and multivariate analyses of preoperative factors influencing symptomatic outcomes of transoral fundoplicationReginald C W Bell, Mark A Fox, William E Barnes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFREzra E W Cohen, Mark W Lingen, Leslie E Martin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2010
Controlled enzymatic production of astrocytic hydrogen peroxide protects neurons from oxidative stress via an Nrf2-independent pathwayRenée E Haskew-Layton, Jimmy B Payappilly, Natalya A Smirnova, et al.
The Journal of Biological Chemistry|October 24, 2000
Proteomics characterization of abundant Golgi membrane proteinsA W Bell, M A Ward, W P Blackstock, et al.
Cancer Research|November 24, 2001
Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni SyndromeS B Lee, S H Kim, D W Bell, et al.
Molecular Cancer Research : MCR|September 10, 2009
Prevalence and functional analysis of sequence variants in the ATR checkpoint mediator ClaspinJianmin Zhang, Young-Han Song, Brian W Brannigan, et al.
Clinical & Translational Immunology|April 24, 2023
Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritisDragana Dragoljevic, Man Kit Sam Lee, Gerard Pernes, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2005
Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinibEunice L Kwak, Raffaella Sordella, Daphne W Bell, et al.
Nature Communications|April 3, 2025
Global floating kelp forests have limited protection despite intensifying marine heatwave threatsNur Arafeh-Dalmau, Juan Carlos Villaseñor-Derbez, David S Schoeman, et al.
Pageof 120

Showing results (871-880 of 1,199) with videos related to

Sort By:
Pageof 120
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Epidermal growth factor receptor mutation testing in the care of lung cancer patientsLecia V Sequist, Victoria A Joshi, Pasi A Jänne, et al.
Surgical Endoscopy|June 1, 2014
Univariate and multivariate analyses of preoperative factors influencing symptomatic outcomes of transoral fundoplicationReginald C W Bell, Mark A Fox, William E Barnes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFREzra E W Cohen, Mark W Lingen, Leslie E Martin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2010
Controlled enzymatic production of astrocytic hydrogen peroxide protects neurons from oxidative stress via an Nrf2-independent pathwayRenée E Haskew-Layton, Jimmy B Payappilly, Natalya A Smirnova, et al.
The Journal of Biological Chemistry|October 24, 2000
Proteomics characterization of abundant Golgi membrane proteinsA W Bell, M A Ward, W P Blackstock, et al.
Cancer Research|November 24, 2001
Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni SyndromeS B Lee, S H Kim, D W Bell, et al.
Molecular Cancer Research : MCR|September 10, 2009
Prevalence and functional analysis of sequence variants in the ATR checkpoint mediator ClaspinJianmin Zhang, Young-Han Song, Brian W Brannigan, et al.
Clinical & Translational Immunology|April 24, 2023
Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritisDragana Dragoljevic, Man Kit Sam Lee, Gerard Pernes, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2005
Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinibEunice L Kwak, Raffaella Sordella, Daphne W Bell, et al.
Nature Communications|April 3, 2025
Global floating kelp forests have limited protection despite intensifying marine heatwave threatsNur Arafeh-Dalmau, Juan Carlos Villaseñor-Derbez, David S Schoeman, et al.
Pageof 120